CAT
Caterpillar Inc.
CAT has the edge over KODK overall, supported by stronger modeled upside and lower modeled downside.
KODK
Eastman Kodak Company
KODK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
KODK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Strong |
KODK's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
KODK PE Valuation
KODK has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
KODK Forward outlook
There aren't enough analyst estimates for KODK to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over KODK on earnings quality, reporting a profit while its opponent remains loss making.
KODK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.12 | -$0.78 |
| Q2 2026 | -$1.38 | -$1.27 |
| Q1 2026 | -$1.87 | -490% |
| Q4 2025 | -$1.78 | -298% |
| Q3 2025 | -$0.34 | -147% |
| Q2 2025 | -$0.11 | -119% |
| Q1 2025 | $0.48 | -28% |
| Q4 2024 | $0.90 | +34% |
KODK is still losing money, but far less than before: $1.12 per share over the past year, against $11.39 at its worst in late 2020.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over KODK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over KODK on profitability, with a higher operating margin.
KODK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $276M | +2.6% |
| Q2 2026 | $311M | +18% |
| Q1 2026 | $265M | +7.3% |
| Q4 2025 | $290M | +9% |
| Q3 2025 | $269M | +3.1% |
| Q2 2025 | $263M | -1.5% |
| Q1 2025 | $247M | -0.8% |
| Q4 2024 | $266M | -3.3% |
KODK's revenue has grown year over year for five quarters in a row: $276M last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.4% | -1.6 points |
| Q2 2026 | 4.8% | +6.7 points |
| Q1 2026 | -0.4% | +4.9 points |
| Q4 2025 | -0.3% | +2.7 points |
| Q3 2025 | 7.1% | +10 points |
| Q2 2025 | -1.9% | -2.6 points |
| Q1 2025 | -5.3% | -8.1 points |
| Q4 2024 | -3% | +1.7 points |
KODK's operating margin was 5.4% last quarter, down 1.6 points from the same quarter a year ago, near the top of its range since 2019.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
KODK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18M | +5.9% |
| Q2 2026 | $0 | +$4M |
| Q1 2026 | -$36M | +$14M |
| Q4 2025 | $483M | +$496M |
| Q3 2025 | $17M | +$58M |
| Q2 2025 | -$4M | +$12M |
| Q1 2025 | -$50M | -814% |
| Q4 2024 | -$13M | -$13M |
KODK has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over KODK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
KODK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +14% | +13M shares |
| 3 years | +29% | +23.3M shares |
| 5 years | +28% | +22.2M shares |
| Available history | +139% | +59.8M shares |
KODK has 103M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | — |
| Q4 2025 | $5M |
| Q3 2025 | — |
| Q2 2025 | $1M |
| Q1 2025 | $1M |
| Q4 2024 | — |
KODK spent $7M buying back its own shares over the past year, about four times what it spent the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
KODK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.7x | Net Cash |
| Q2 2026 | -3.0x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -4.4x | Net Cash |
| Q3 2025 | 16.1x | High |
| Q1 2025 | 317.0x | High |
| Q4 2024 | 12.7x | High |
| Q3 2024 | 15.4x | High |
KODK has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
KODK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.5 | Neutral |
| Stochastic | 31.5 | Neutral |
KODK's weekly RSI is 46 (neutral) and its Stochastic is 32 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
KODK PE vs Industrials Sector
| Metric | KODK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
KODK has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
KODK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.00 | 5.6% below |
| 20 week MA | $9.00 | 5.6% below |
| 50 week MA | $9.11 | 6.7% below |
| 100 week MA | $7.82 | 8.7% above |
| 200 week MA | $6.19 | 37% above |
KODK has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over KODK on returns for 2026, with the stronger performance.
KODK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.83 | $8.72 | +128% |
| 2021 | $8.72 | $5.11 | -41% |
| 2022 | $5.11 | $3.09 | -40% |
| 2023 | $3.09 | $3.90 | +26% |
| 2024 | $3.90 | $7.01 | +80% |
| 2025 | $7.01 | $8.74 | +25% |
| 2026 YTD | $8.74 | $8.50 | -2.7% |
KODK's yearly returns have swung widely, from +128% in 2020 to −41% in 2021. It's down 2.7% so far in 2026.